Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04754191
Title Enfortumab Vedotin as Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer (ENCORE)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors University of Utah
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.